{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified=2015-02-08T09%3A10%3A14.233Z&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?ddpModified=2015-02-08T09%3A10%3A14.233Z&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified=2015-02-08T09%3A10%3A14.233Z&_metadata=all&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&ddpModified=2015-02-08T09%3A10%3A14.233Z&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified=2015-02-08T09%3A10%3A14.233Z&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?ddpModified=2015-02-08T09%3A10%3A14.233Z&max-answer.questionFirstAnswered.=2014-12-02T15%3A17%3A44.033Z", "items" : [{"_about" : "http://data.parliament.uk/resources/155953", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/155953/answer", "answerText" : {"_value" : "
We have no plans to set such targets or goals.<\/p>
<\/p>
<\/p>
<\/p>
Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed \u2018off-label\u2019 outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.<\/p>
<\/p>
<\/p>
<\/p>
We are in the process of setting up a round-table discussion with key stakeholders, including NHS England and the National Institute for Health and Care Excellence to explore opportunities for supporting appropriate use of off-label drugs outside their licensed indications where the evidence supports this.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-11-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-24T17:35:43.843Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Licensing"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will set targets and goals for speeding up the use of off-patent drugs outside their licensed indications, where evidence supports that use.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "214424"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }